Depletion of glioma stem cells by synergistic inhibition of mTOR and c-Myc with a biological camouflaged cascade brain-targeting nanosystem

Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy

(2020) Cheng-Hui Xu et al.   Acta Biomaterialia

On-demand drug release nanoplatform based on fluorinated aza-BODIPY for imaging-guided chemo-phototherapy

(2020) Jiaojiao Zhang et al.   BIOMATERIALS

Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis

(2019) Rajashekhar Kanchanapally et al.   International Journal of Nanomedicine

A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination

(2019) Kensuke Takaoka et al.   LEUKEMIA

Meningitic Escherichia coli-induced upregulation of PDGF-B and ICAM-1 aggravates blood-brain barrier disruption and neuroinflammatory response

(2019) Rui-Cheng Yang et al.   Journal of Neuroinflammation

Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems

(2018) Max Piffoux et al.   ACS Nano

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

(2018) Xiaoyue Chen et al.   Nature Communications

Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment

(2018) Sophie Pinel et al.   ADVANCED DRUG DELIVERY REVIEWS

Drug and disease signature integration identifies synergistic combinations in glioblastoma

(2018) Vasileios Stathias et al.   Nature Communications

Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination

(2016) Xiaoguang Fang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis

(2016) Qi Cui et al.   Nature Communications

Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells

(2016) Lorena Favaro Pavon et al.   Oncotarget

c-Myc–miR-29c–REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma

(2015) Hui Luo et al.   BRAIN

The Blood–Brain Barrier

(2015) Richard Daneman et al.   Cold Spring Harbor Perspectives in Biology

Redox-Responsive Magnetic Nanoparticle for Targeted Convection-Enhanced Delivery of O6-Benzylguanine to Brain Tumors

(2014) Zachary R. Stephen et al.   ACS Nano

Modulation of Drug Resistance in Ovarian Adenocarcinoma Using Chemotherapy Entrapped in Hyaluronan-Grafted Nanoparticle Clusters

(2014) Keren Cohen et al.   ACS Nano

MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling

(2014) J. X. Zhang et al.   ANNALS OF ONCOLOGY

Specific Binding, Uptake, and Transport of ICAM-1-Targeted Nanocarriers Across Endothelial and Subendothelial Cell Components of the Blood–Brain Barrier

(2014) Janet Hsu et al.   PHARMACEUTICAL RESEARCH

Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis

(2014) Daniela Annibali et al.   Nature Communications

mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc

(2013) Kenta Masui et al.   Cell Metabolism

Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system

(2011) Tatsuaki Tagami et al.   JOURNAL OF CONTROLLED RELEASE

Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction

(2009) M. Jechlinger et al.   GENES & DEVELOPMENT

Structure and function of the blood–brain barrier

(2009) N. Joan Abbott et al.   NEUROBIOLOGY OF DISEASE